Outlook Therapeutics Inc
F:41O
Outlook Therapeutics Inc
F:41O
Precio:
1,07
EUR
-10,61%
Mercado cerrado
Capitalización de mercado:
€47,53 M
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
Outlook Therapeutics Inc
F:41O
|
US |
|
M
|
MetLife Inc
DUS:MWZ
|
US |
|
Ziprecruiter Inc
NYSE:ZIP
|
US |
|
P
|
PPC Ltd
JSE:PPC
|
ZA |
|
Jensen-Group NV
XBRU:JEN
|
BE |
|
Hackett Group Inc
NASDAQ:HCKT
|
US |
|
E
|
EQT Corp
SWB:EQ6
|
US |
|
Z
|
Zai Lab Ltd
SWB:1ZL
|
CN |
|
Ameresco Inc
LSE:0A70
|
US |
|
Heritage Insurance Holdings Inc
F:11H
|
US |
|
N
|
Neo Performance Materials Inc
OTC:NOPMF
|
CA |
|
I
|
Isetan Mitsukoshi Holdings Ltd
XBER:4HP
|
JP |
|
H
|
Hankook Tire & Technology Co Ltd
KRX:161390
|
KR |
|
C
|
Carlsberg A/S
F:CBGB
|
DK |
|
Cedar Fair LP
NYSE:FUN
|
US |
|
I
|
Icelandair Group hf
ICEX:ICEAIR
|
IS |
|
Hawaiian Electric Industries Inc
NYSE:HE
|
US |
|
Pennon Group PLC
LSE:PNN
|
UK |
|
Western Digital Corp
NASDAQ:WDC
|
US |
|
T
|
TUI AG
XETRA:TUI1
|
DE |
|
C
|
Conduent Inc
F:4C0
|
US |
|
H
|
Hackett Group Inc
F:AWT
|
US |
|
C
|
Cellectis SA
SWB:ZVAA
|
FR |
|
Newlat Food SpA
MIL:NWL
|
IT |
Balance general
Desglose del balance general
Outlook Therapeutics Inc
Outlook Therapeutics Inc
El desglose del balance general no está disponible para
Outlook Therapeutics Inc
Outlook Therapeutics Inc
Balance general
Outlook Therapeutics Inc
Outlook Therapeutics Inc
Moneda: USD
| Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activos | ||||||||||||
| Efectivo y equivalentes de efectivo |
2
|
9
|
2
|
3
|
2
|
8
|
13
|
14
|
17
|
23
|
0
|
|
| Efectivo |
2
|
9
|
2
|
3
|
2
|
8
|
13
|
14
|
17
|
0
|
0
|
|
| Equivalentes de efectivo |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
0
|
|
| Cuentas por cobrar totales |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cuentas por cobrar comerciales |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Otras cuentas por cobrar |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Otros activos corrientes |
1
|
2
|
3
|
1
|
2
|
5
|
5
|
7
|
10
|
8
|
12
|
|
| Activos corrientes totales |
3
|
15
|
6
|
4
|
3
|
14
|
18
|
22
|
28
|
31
|
27
|
|
| PP&E neto |
8
|
18
|
19
|
16
|
18
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E bruto |
8
|
18
|
19
|
16
|
18
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciación acumulada |
2
|
4
|
6
|
9
|
12
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Inversiones a largo plazo |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Otros activos a largo plazo |
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Activos totales |
12
N/A
|
35
+202%
|
25
-27%
|
21
-18%
|
22
+7%
|
17
-23%
|
20
+15%
|
23
+16%
|
29
+25%
|
32
+13%
|
29
-10%
|
|
| Pasivos | ||||||||||||
| Cuentas por pagar |
3
|
12
|
5
|
11
|
4
|
2
|
2
|
2
|
3
|
7
|
8
|
|
| Pasivos acumulados |
3
|
6
|
6
|
7
|
6
|
5
|
8
|
2
|
3
|
3
|
3
|
|
| Deuda a corto plazo |
0
|
0
|
0
|
0
|
13
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Porción corriente de la deuda a largo plazo |
11
|
16
|
6
|
5
|
5
|
5
|
4
|
1
|
11
|
36
|
29
|
|
| Otros pasivos corrientes |
3
|
4
|
3
|
5
|
4
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Pasivos corrientes totales |
20
|
37
|
20
|
29
|
32
|
20
|
16
|
7
|
20
|
47
|
43
|
|
| Deuda a largo plazo |
4
|
6
|
3
|
13
|
4
|
3
|
1
|
11
|
0
|
0
|
0
|
|
| Interés minoritario |
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Otros pasivos |
8
|
19
|
8
|
9
|
8
|
4
|
0
|
1
|
0
|
0
|
59
|
|
| Pasivos totales |
35
N/A
|
64
+81%
|
31
-52%
|
51
+68%
|
43
-16%
|
28
-35%
|
17
-39%
|
18
+8%
|
20
+9%
|
47
+136%
|
102
+118%
|
|
| Patrimonio | ||||||||||||
| Acciones ordinarias |
22
|
65
|
0
|
3
|
5
|
6
|
1
|
2
|
2
|
3
|
0
|
|
| Ganancias retenidas |
45
|
94
|
147
|
186
|
216
|
254
|
290
|
343
|
409
|
468
|
543
|
|
| Capital adicional pagado |
0
|
0
|
142
|
152
|
190
|
238
|
291
|
346
|
415
|
451
|
470
|
|
| Patrimonio total |
24
N/A
|
29
-21%
|
5
+82%
|
31
-494%
|
21
+32%
|
11
+48%
|
3
N/A
|
5
+63%
|
9
+90%
|
14
N/A
|
73
-406%
|
|
| Total pasivos y patrimonio |
12
N/A
|
35
+202%
|
25
-27%
|
21
-18%
|
22
+7%
|
17
-23%
|
20
+15%
|
23
+16%
|
29
+25%
|
32
+13%
|
29
-10%
|
|
| Acciones en circulación | ||||||||||||
| Acciones ordinarias en circulación |
0
|
0
|
0
|
0
|
0
|
1
|
6
|
9
|
11
|
13
|
24
|
|
| Acciones preferentes en circulación |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Continuar investigando 41O
Other Outlook Therapeutics Inc listings:
Descubrir más
